Luke V. Blakeway

551 total citations
22 papers, 298 citations indexed

About

Luke V. Blakeway is a scholar working on Epidemiology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Luke V. Blakeway has authored 22 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Molecular Biology and 9 papers in Molecular Medicine. Recurrent topics in Luke V. Blakeway's work include Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Luke V. Blakeway is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (9 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Luke V. Blakeway collaborates with scholars based in Australia, United States and United Kingdom. Luke V. Blakeway's co-authors include Kate L. Seib, Ian R. Peak, Aimee Tan, Adam Jenney, Jane Hawkey, Kathryn E. Holt, Ryan R. Wick, Louise M. Judd, Anton Y. Peleg and Kelly L. Wyres and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Luke V. Blakeway

19 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke V. Blakeway Australia 10 121 94 91 57 47 22 298
Zengyuan Yu China 8 149 1.2× 85 0.9× 66 0.7× 33 0.6× 56 1.2× 16 342
Ali F. Aboklaish United Kingdom 8 170 1.4× 77 0.8× 52 0.6× 52 0.9× 36 0.8× 13 282
Aleksandra Kozińska Poland 12 80 0.7× 70 0.7× 97 1.1× 58 1.0× 43 0.9× 23 310
Jiayue Ma China 8 161 1.3× 75 0.8× 76 0.8× 40 0.7× 65 1.4× 17 324
Blanca Gatti Argentina 8 72 0.6× 69 0.7× 66 0.7× 57 1.0× 72 1.5× 13 295
Seiya Kashiyama Japan 10 129 1.1× 38 0.4× 92 1.0× 41 0.7× 70 1.5× 28 296
Alicja Sękowska Poland 10 154 1.3× 62 0.7× 67 0.7× 22 0.4× 93 2.0× 45 307
Anaëlle Muggeo France 10 157 1.3× 56 0.6× 52 0.6× 21 0.4× 67 1.4× 23 271
Amer El Ghali United States 9 171 1.4× 44 0.5× 111 1.2× 57 1.0× 29 0.6× 14 326
Yeshimebet Kassa Ethiopia 6 226 1.9× 72 0.8× 124 1.4× 37 0.6× 89 1.9× 10 361

Countries citing papers authored by Luke V. Blakeway

Since Specialization
Citations

This map shows the geographic impact of Luke V. Blakeway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke V. Blakeway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke V. Blakeway more than expected).

Fields of papers citing papers by Luke V. Blakeway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke V. Blakeway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke V. Blakeway. The network helps show where Luke V. Blakeway may publish in the future.

Co-authorship network of co-authors of Luke V. Blakeway

This figure shows the co-authorship network connecting the top 25 collaborators of Luke V. Blakeway. A scholar is included among the top collaborators of Luke V. Blakeway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke V. Blakeway. Luke V. Blakeway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subedi, Dinesh, Fernando Gordillo Altamirano, Ruzeen Patwa, et al.. (2025). Rational design of a hospital-specific phage cocktail to treat Enterobacter cloacae complex infections. Nature Microbiology. 10(11). 2702–2719. 2 indexed citations
2.
Maćešić, Nenad, Jessica A. Wisniewski, Luke V. Blakeway, et al.. (2025). Hospital Enterococcus faecium demonstrates distinct environmental and patient reservoirs: a genomic point prevalence survey. Infection Control and Hospital Epidemiology. 46(5). 540–543. 1 indexed citations
3.
Peleg, Anton Y., Jiangning Song, Jessica A. Wisniewski, et al.. (2025). Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study. Clinical Microbiology and Infection. 32(1). 110–117.
4.
Maćešić, Nenad, Adelaide S. M. Dennis, Jane Hawkey, et al.. (2024). Genomic investigation of multispecies and multivariant blaNDM outbreak reveals key role of horizontal plasmid transmission. Infection Control and Hospital Epidemiology. 45(6). 709–716. 2 indexed citations
5.
Peleg, Anton Y., Jiangning Song, Bhavna Antony, et al.. (2024). Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra. mSystems. 9(9). e0078924–e0078924. 12 indexed citations
6.
Kostoulias, Xenia, Ying Fu, Faye C. Morris, et al.. (2024). Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions. Journal of Antimicrobial Chemotherapy. 80(2). 372–380. 1 indexed citations
7.
Jiang, Jhih‐Hang, Anton Y. Peleg, Luke V. Blakeway, et al.. (2023). Characterisation of key genotypic and phenotypic traits of clinical cystic fibrosis Staphylococcus aureus isolates. Journal of Medical Microbiology. 72(6). 1 indexed citations
8.
Maćešić, Nenad, Jane Hawkey, Ben Vezina, et al.. (2023). Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer. Nature Communications. 14(1). 24 indexed citations
9.
Hawkey, Jane, Kelly L. Wyres, Louise M. Judd, et al.. (2022). ESBL plasmids in Klebsiella pneumoniae: diversity, transmission and contribution to infection burden in the hospital setting. Genome Medicine. 14(1). 97–97. 39 indexed citations
10.
Loftus, Michael J., Luke V. Blakeway, Allen Cheng, et al.. (2022). Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study. The Lancet Regional Health - Western Pacific. 22. 100438–100438. 12 indexed citations
11.
Bhangu, Sukhvir Kaur, Haiyan Zhu, Anton Y. Peleg, et al.. (2022). Chemoenzymatic surface decoration of Nisin-shelled nanoemulsions: Novel targeted drug-nanocarriers for cancer applications. Ultrasonics Sonochemistry. 90. 106183–106183. 7 indexed citations
12.
Maćešić, Nenad, Luke V. Blakeway, James Stewart, et al.. (2021). Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales. Clinical Microbiology and Infection. 27(12). 1856.e7–1856.e13. 49 indexed citations
13.
Blakeway, Luke V., Aimee Tan, Ian R. Peak, John M. Atack, & Kate L. Seib. (2020). Proteome of a Moraxella catarrhalis Strain under Iron-Restricted Conditions. Microbiology Resource Announcements. 9(12). 2 indexed citations
14.
Tan, Aimee, Luke V. Blakeway, Yuedong Yang, et al.. (2020). Moraxella catarrhalis phase-variable loci show differences in expression during conditions relevant to disease. PLoS ONE. 15(6). e0234306–e0234306. 4 indexed citations
15.
Blakeway, Luke V., Aimee Tan, Ian R. Peak, John M. Atack, & Kate L. Seib. (2020). Transcriptome RNA Sequencing Data Set of Gene Expression in Moraxella catarrhalis On- and Off-Phase Variants of the Type III DNA Methyltransferase ModM3. Microbiology Resource Announcements. 9(14).
16.
Blakeway, Luke V., Aimee Tan, Joseph A. Jurcisek, et al.. (2019). The Moraxella catarrhalis phase-variable DNA methyltransferase ModM3 is an epigenetic regulator that affects bacterial survival in an in vivo model of otitis media. BMC Microbiology. 19(1). 276–276. 14 indexed citations
17.
18.
Blakeway, Luke V., Aimee Tan, Rachael Lappan, et al.. (2018). Moraxella catarrhalis Restriction-Modification Systems are Associated with Phylogenetic Lineage and Disease. Genome Biology and Evolution. 10(11). 2932–2946. 15 indexed citations
19.
Tan, Aimee, Luke V. Blakeway, Lauren O. Bakaletz, et al.. (2017). Complete Genome Sequence of Moraxella catarrhalis Strain CCRI-195ME, Isolated from the Middle Ear. Genome Announcements. 5(21). 6 indexed citations
20.
Blakeway, Luke V., Peter M. Power, Freda E.‐C. Jen, et al.. (2014). ModM DNA methyltransferase methylome analysis reveals a potential role for Moraxella catarrhalis phasevarions in otitis media. The FASEB Journal. 28(12). 5197–5207. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zengyuan Yu Breakdown of academic impact, for papers by Ali F. Aboklaish Breakdown of academic impact, for papers by Aleksandra Kozińska Breakdown of academic impact, for papers by Jiayue Ma Breakdown of academic impact, for papers by Blanca Gatti Breakdown of academic impact, for papers by Seiya Kashiyama Breakdown of academic impact, for papers by Alicja Sękowska Breakdown of academic impact, for papers by Anaëlle Muggeo Breakdown of academic impact, for papers by Amer El Ghali Breakdown of academic impact, for papers by Yeshimebet Kassa
Rankless by CCL
2026